A Phase 1, Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Adult and Elderly Subjects

Trial Profile

A Phase 1, Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Adult and Elderly Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs TD 0714 (Primary)
  • Indications Cardiovascular disorders; Kidney disorders
  • Focus Adverse reactions
  • Sponsors Theravance Biopharma
  • Most Recent Events

    • 17 Nov 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.
    • 08 Nov 2016 Status changed from active, no longer recruiting to completed, as per Theravance Biopharma media release.
    • 25 Oct 2016 According to Theravance Biopharma media release, the company has announced positive results, including biomarker data from this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top